Beijing-based Concord Medical Services Holdings Ltd. said its Guangzhou Concord Cancer Center is collaborating with Macao Kiang Wu hospital to build a cancer specialist alliance and a multidisciplinary consultation platform to promote cancer treatment, education, research and other fields of proton radiation therapy.
Dominion Aesthetic Technologies Inc., headquartered in San Antonio, reported a strategic relationship with Worcester, Mass.-based Cogmedix Inc., a wholly owned subsidiary of Coghlin Companies, for the production of Eon, a touchless, robotic laser and body contouring device.
San Diego-based Formsense has been selected as a technology partner for a $2.4 million NIH grant. The money will help to deploy and test a mobile health system, leveraging Formsense’s wearable smart ring sensor, to monitor and encourage movement and activity in the upper limbs of stroke survivors in an ambulatory setting.
Singapore-based Genesis Medtech International Pvt. Ltd. has completed its acquisition of the Chocolate Touch drug-coated balloon from Trireme Medical LLC, a wholly owned subsidiary of Singapore-based Qt Vascular Ltd. Financial terms of the transaction were not disclosed.
Nowdiagnostics Inc., of Springdale, Ark., said it is working with HHS’ Biomedical Advanced Research and Development Authority to develop a serological test for SARS-CoV-2 antibodies that can be used across a variety of health care settings, including at-home use. The point-of-care test using Nowdiagnostics’ Adexusdx platform requires no additional materials, equipment, processing or refrigeration, and delivers results in 15 minutes.
Ontrak Inc., an artificial intelligence-powered and telehealth-enabled virtual outpatient care company based in Santa Monica, Calif., said its common stock has been listed on the Nasdaq Global Market under the ticker OTRK.
Todos Medical Ltd., of Rehovot, Israel, reported a $23.76 million contract for COVID-19 polymerase chain reaction (PCR) testing equipment and supplies with a Wisconsin-based laboratory. The initial contract is for eight months. Todos has also been granted a priority right to supply the lab with up to 100,000 COVID PCR tests per day if the need arises. The customer has an agreement with the State of Wisconsin to supply COVID-19 PCR tests.